Federal contractor · SEOUL

NAMU MED

NAMU MED received $55K in federal contract obligations in FY2026, on 1 awards (+31% vs FY2025). Since FY2017: $1M. Its largest customer was Defense Health Agency ($55K).

Obligations · FY2026
$55K
New awards
1
Sole-source
0.0%
Single offer
0.0%
UEI
FKMJKCM6K5A3
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 57.7KFY2017
  2. 105.2KFY2018
  3. 182.5KFY2019
  4. 241.4KFY2020
  5. 112.7KFY2021
  6. 45KFY2022
  7. 130KFY2023
  8. 46.9KFY2024
  9. 42.1KFY2025
  10. 55KFY2026

Top buying agencies

Obligations in FY2026.

  1. Defense Health Agency$55K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$55K100%

Where the work was performed

  1. Baltimore County, MD$55K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.8% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. BIOCHEMICAL ANTIGIOTIC TESTING, BDAACH$55K
    Defense Health Agency· Baltimore County, MD· Health & medical· Sep 5, 2025 – Apr 14, 2026· W81K0225FA130

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

  1. SYNYOUNG BIOMEDICS$198.1K0% in FY2026
    SEOUL, KOR · 100% of this company's obligations are in markets they both serveArmy · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturing
  2. THE REPUBLIC OF KOREA NATIONAL RED CROSS$96K−27% in FY2026
    SUWON, KOR · 67% of this company's obligations are in markets they both serveArmy · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturing
  3. CHENKWANG SCIENCE$87.7K+11% in FY2026
    GUNPO-SI, KOR · 61% of this company's obligations are in markets they both serveArmy · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.